Variant report
Variant | esv3385303 |
---|---|
Chromosome Location | chr6:38821376-38821837 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:38819628..38821796-chr6:38823200..38825127,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs189011462 | chr6:38821391-38821392 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs112470129 | chr6:38821398-38821399 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs147843227 | chr6:38821399-38821400 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs72852705 | chr6:38821418-38821419 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs193149277 | chr6:38821436-38821437 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs80027868 | chr6:38821471-38821472 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs529191956 | chr6:38821492-38821493 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs548661987 | chr6:38821508-38821509 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs568877158 | chr6:38821535-38821536 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs540377796 | chr6:38821570-38821571 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs117951146 | chr6:38821594-38821595 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs117624633 | chr6:38821666-38821667 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs141292255 | chr6:38821677-38821678 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs115219531 | chr6:38821698-38821699 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs554366341 | chr6:38821716-38821717 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs75930745 | chr6:38821723-38821724 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs145032224 | chr6:38821737-38821738 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs375525499 | chr6:38821744-38821745 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs9357285 | chr6:38821752-38821753 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs576073209 | chr6:38821753-38821754 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs545084862 | chr6:38821766-38821767 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs138297793 | chr6:38821786-38821787 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs371568318 | chr6:38821801-38821802 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs376690557 | chr6:38821802-38821803 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs556090853 | chr6:38821814-38821815 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs72852707 | chr6:38821816-38821817 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Cervical cancer | 21062161 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Cleidocranial dysplasia | 18696259 | CNVD |
Holoprosencephaly | 21359414 | CNVD |
Liposarcoma | 21253554 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Fibroblasts | 20926602 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Lung cancer | 19153074 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Melanoma | 21693616 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Mental retardation | 21062444 | CNVD |
Breast cancer | 16397240 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Osteosarcoma | 21197465 | CNVD |
Gastric cancer | 24379144 | CNVD |
Neuroblastoma | 18923191 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 17603634 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Cancer | 20164919 | CNVD |
Glioblastoma multiforme | 21510904 | CNVD |
Amyotrophic lateral sclerosis | 20685689 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:38766800-38824400 | Weak transcription | K562 | blood |
2 | chr6:38821000-38821400 | Enhancers | H9 Cell Line | embryonic stem cell |
3 | chr6:38821000-38821600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
4 | chr6:38821000-38821600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
5 | chr6:38821000-38821600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |